These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34371130)

  • 21. Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors.
    Said MA; Eldehna WM; Nocentini A; Bonardi A; Fahim SH; Bua S; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2020 Jan; 185():111843. PubMed ID: 31718943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII.
    Saluja AK; Tiwari M; Vullo D; Supuran CT
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1310-4. PubMed ID: 24507918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New selective carbonic anhydrase IX inhibitors: synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides.
    Rogez-Florent T; Meignan S; Foulon C; Six P; Gros A; Bal-Mahieu C; Supuran CT; Scozzafava A; Frédérick R; Masereel B; Depreux P; Lansiaux A; Goossens JF; Gluszok S; Goossens L
    Bioorg Med Chem; 2013 Mar; 21(6):1451-64. PubMed ID: 23168081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tricyclic sulfonamides incorporating benzothiopyrano[4,3-c]pyrazole and pyridothiopyrano[4,3-c]pyrazole effectively inhibit α- and β-carbonic anhydrase: X-ray crystallography and solution investigations on 15 isoforms.
    Marini AM; Maresca A; Aggarwal M; Orlandini E; Nencetti S; Da Settimo F; Salerno S; Simorini F; La Motta C; Taliani S; Nuti E; Scozzafava A; McKenna R; Rossello A; Supuran CT
    J Med Chem; 2012 Nov; 55(22):9619-29. PubMed ID: 23067387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases.
    Karalı N; Akdemir A; Göktaş F; Eraslan Elma P; Angeli A; Kızılırmak M; Supuran CT
    Bioorg Med Chem; 2017 Jul; 25(14):3714-3718. PubMed ID: 28545816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syntesis of thio- and seleno-acetamides bearing benzenesulfonamide as potent inhibitors of human carbonic anhydrase II and XII.
    Tanini D; Capperucci A; Scopelliti M; Milaneschi A; Angeli A; Supuran CT
    Bioorg Chem; 2019 Aug; 89():102984. PubMed ID: 31112841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
    Khloya P; Ceruso M; Ram S; Supuran CT; Sharma PK
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3208-12. PubMed ID: 26105196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigations.
    Ivanova J; Balode A; Žalubovskis R; Leitans J; Kazaks A; Vullo D; Tars K; Supuran CT
    Bioorg Med Chem; 2017 Feb; 25(3):857-863. PubMed ID: 28024887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
    Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
    Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
    Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
    Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity.
    Mojzych M; Bielawska A; Bielawski K; Ceruso M; Supuran CT
    Bioorg Med Chem; 2014 May; 22(9):2643-7. PubMed ID: 24713308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition of human carbonic anhydrases by novel amide derivatives of probenecid: synthesis, biological evaluation and molecular modelling studies.
    D'Ascenzio M; Carradori S; Secci D; Vullo D; Ceruso M; Akdemir A; Supuran CT
    Bioorg Med Chem; 2014 Aug; 22(15):3982-8. PubMed ID: 25027802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors.
    Chiaramonte N; Bua S; Angeli A; Ferraroni M; Picchioni I; Bartolucci G; Braconi L; Dei S; Teodori E; Supuran CT; Romanelli MN
    Bioorg Chem; 2019 Oct; 91():103130. PubMed ID: 31374520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
    Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
    Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety.
    Sethi KK; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5168-74. PubMed ID: 23867389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
    Ghorab MM; Soliman AM; Bua S; Supuran CT
    Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzylaminoethyureido-Tailed Benzenesulfonamides: Design, Synthesis, Kinetic and X-ray Investigations on Human Carbonic Anhydrases.
    Ali M; Bozdag M; Farooq U; Angeli A; Carta F; Berto P; Zanotti G; Supuran CT
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.